Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Past and future technologic developments for rhythm and conduction disturbances.

J Warren1

  • 1Guidant Corporation, St. Paul, Minnesota 55112-5798, USA.

The American Journal of Cardiology
|November 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting Longitudinal Caries Trajectories from Childhood to Early Adulthood.

Journal of dental research·2026
Same author

Community Opioid Dispensing after Injury (CODI): Cohort characteristics and opioid dispensing patterns.

Injury·2023
Same author

Predicting Dental Caries in Young Children in Primary Health Care Settings.

Journal of dental research·2023
Same author

Posterior mesh inguinal hernia repairs: a propensity score matched analysis of laparoscopic and robotic versus open approaches.

Hernia : the journal of hernias and abdominal wall surgery·2022
Same author

Predictors of low and high opioid tablet consumption after inguinal hernia repair: an ACHQC opioid reduction task force analysis.

Hernia : the journal of hernias and abdominal wall surgery·2022
Same author

Neutron-upscattering enhancement of the triple-alpha process.

Nature communications·2022
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Technological advancements in implantable cardiac devices have improved patient outcomes and streamlined procedures. Future innovations promise smaller devices, enhanced features, and predictive capabilities for event prevention.

Area of Science:

  • Biomedical Engineering
  • Cardiology
  • Medical Device Technology

Background:

  • The first cardiac pacemaker was implanted in 1958.
  • Technological innovations have continuously enhanced implantable cardiac device therapy.
  • These advancements benefit patients and physicians by expanding treatable conditions and simplifying procedures.

Purpose of the Study:

  • To review the historical development of implantable cardiac devices.
  • To present concepts guiding future technological innovations in the field.
  • To highlight the expected trajectory of device miniaturization, feature enhancement, and data capabilities.

Main Methods:

  • Historical review of implantable cardiac device technology.
  • Analysis of trends in device size, functionality, and data transmission.

Related Experiment Videos

  • Discussion of future concepts and their potential impact on cardiac therapy.

    • Main Results:

    • Implantable cardiac device therapy has evolved significantly since 1958.
    • Ongoing innovations are leading to smaller, more automated devices with advanced diagnostic capabilities.
    • Future devices are expected to enable prediction and prevention of cardiac events.

    Conclusions:

    • Continued technological innovation is driving progress in implantable cardiac device therapy.
    • Future advancements will focus on miniaturization, increased automaticity, and predictive analytics.
    • These developments will further improve the management of cardiac conditions and patient care.